Concepedia

Paul Gibbons

PG

Statistics

Publications

32

Citations

1.7K

H-Index

23

Active since

1959

Affiliations

WuXi AppTec (China)(Current)

Health and Functional Exposomics

Gene Therapy Laboratory

University of California, San Francisco

Diamond Light Source

Paul Gibbons is an author at WuXi AppTec (China) specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

1959–2021

32

Publications

32

Structure-guided design of a selective BCL-XL inhibitor

Guillaume Lessène, Peter E. Czabotar, Brad E. Sleebs et al. · Nature Chemical Biology · 2013 · 374 citations · Full text

, , +14

Lead identification of novel and selective TYK2 inhibitors

Jun Liang, Vickie Tsui, Anne van Abbema et al. · European Journal of Medicinal Chemistry · 2013 · 123 citations · Full text

, , +14

Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors

Jun Liang, Anne van Abbema, Mercedesz Balázs et al. · Journal of Medicinal Chemistry · 2013 · 97 citations · Full text

, , +17

Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors

Janusz J. Kulagowski, Wade Blair, Richard J. Bull et al. · Journal of Medicinal Chemistry · 2012 · 94 citations · Full text

, , +15

Discovery of Dual Leucine Zipper Kinase (DLK, MAP3K12) Inhibitors with Activity in Neurodegeneration Models

Snahel Patel, Frederick Cohen, Brian J. Dean et al. · Journal of Medicinal Chemistry · 2014 · 91 citations · Full text

, , +16

1–5 of 32